Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

WSE/BAY stock hub

WSE/BAY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/BAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

153.7B

Warsaw Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

WSE/BAY

In the news

Latest news · WSE/BAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.7

P25 9.9P50 16.8P75 19.7

Trailing P/En/a

P25 15.2P50 20.9P75 63

ROE-12.4

P25 -39.9P50 -16.3P75 7.2

ROIC8.7

P25 -44.1P50 -13.4P75 4.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/BAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

EUR

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	PL
Employees	87,280
Employees Change	-4,584%
Employees Change Percent	-4.99
Enterprise value	PLN 280B
Exchange	Warsaw Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	DE000BAY0017
Last refreshed	2026-05-10
Market cap	PLN 153.7B
Price	PLN 156
Price currency	PLN
Rev Per Employee	2,203,205.6x
Sector	Healthcare
Sic	2800
Symbol	wse/BAY
Website	https://www.bayer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.93%
EV Earnings	-18.33x
EV/EBIT	13.12x
EV/EBITDA	7.25x
EV/FCF	19.28x
EV/Sales	1.45x
FCF yield	9.45%
Forward P/E	8.71x
P/B ratio	1.4x
P/S ratio	0.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.22%
EBITDA Margin	19.46%
FCF margin	7.55%
Gross margin	59.35%
Gross Profit	PLN 114.1B
Gross Profit Growth	4.94%
Gross Profit Growth Q	11.82%
Gross Profit Growth3 Y	-5.3%
Gross Profit Growth5 Y	1.05%
Net Income	PLN -15.3B
Net Income Growth Years	0%
Pretax Margin	-6.87%
Profit Margin	-7.94%
Profit Per Employee	PLN -175,000
ROA	2.97
Roa5y	3.38
ROCE	7.11
ROE	-12.37
Roe5y	-2.72
ROIC	8.68
Roic5y	8.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.62%
EPS Growth Years	0
FCF Growth	-24.99%
FCF Growth Q	-12.67%
FCF Growth3 Y	-5.99%
FCF Growth5 Y	6.74%
OCF Growth	-19.52%
OCF Growth Q	-15.91%
OCF Growth10 Y	-1.49%
OCF Growth3 Y	-5.79%
OCF Growth5 Y	3.88%
Revenue Growth	-2.21x
Revenue Growth Q	-2.48x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.51x
Revenue Growth5 Y	1.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.42
Assets	PLN 441.1B
Cash	PLN 33.1B
Current Assets	PLN 139.5B
Current Liabilities	PLN 138.2B
Debt	PLN 158.6B
Debt EBITDA	PLN 4.08
Debt Equity	PLN 1.44
Debt FCF	PLN 10.91
Equity	PLN 110B
Interest Coverage	2.65
Liabilities	PLN 331.1B
Long Term Assets	PLN 301.5B
Long Term Liabilities	PLN 193B
Net Cash	PLN -125.4B
Net Cash By Market Cap	PLN -81.57
Net Debt EBITDA	PLN 3.35
Net Debt Equity	PLN 1.14
Net Debt FCF	PLN 8.63
Tangible Book Value	PLN -95.9B
Tangible Book Value Per Share	PLN -97.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	1.43
Net Working Capital	PLN -7.5B
Quick ratio	0.61
Working Capital	PLN 1.4B
Working Capital Turnover	PLN 66.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-0.78%
Dividend Growth Years	0%
Dividend per share	PLN 0.47
Dividend Years	3
Dividend Yield	0.29%
Ex Div Date	2026-04-27
Last Dividend	PLN 0.47
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.58%
200-day SMA	128
50-day SMA	174.6
50-day SMA vs 200-day SMA	50over200
All Time High	241
All Time High Change	-35.25%
All Time High Date	2023-09-12
All Time Low	78.97
All Time Low Change	97.61%
All Time Low Date	2024-12-23
ATR	4.09
Ch YTD	1.38
High	156.1
High52	198.2
High52 Date	2026-02-12
High52ch	-21.26%
Low	156.1
Low52	93.59
Low52 Date	2025-05-15
Low52ch	66.74%
Ma50ch	-10.6%
Price vs 200-day SMA	21.92%
RSI	38.34
RSI Monthly	51.51
RSI Weekly	56.52
Sharpe ratio	0.71x
Sortino ratio	1.2
Total Return	0.29%
Tr YTD	1.67
Tr1m	-6.85%
Tr1w	-3.67%
Tr3m	-16.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN 21.6B
Operating Income Growth	64.14
Operating Income Growth Q	-0.03
Operating Income Growth3 Y	-17.55
Operating Income Growth5 Y	-6.01
Operating margin	11.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	982,424,082%
Net Borrowing	-8,671,019,750.9
Shares Institutions	36.68%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN 14.5B
Average Volume	117.5x
Bv Per Share	111.4
CAPEX	PLN -10.5B
Ch1m	-7.11
Ch1w	-3.67
Ch1y	54.14
Ch3m	-16.93
Ch6m	36.07
Change	-1.27%
Change From Open	0
Close	158.1
Days Gap	-1.27
Depreciation Amortization	15,925,843,610.9
Dollar Volume	78,025
Earnings Date	2026-05-12
EBIT	PLN 21.6B
EBITDA	PLN 37.4B
EPS	PLN -15.55
F Score	6
FCF	PLN 14.5B
FCF EV Yield	5.19x
Financing CF	-16,387,862,394
Fiscal Year End	December
Founded	1,863
Goodwill	118,981,655,369
Income Tax	PLN 2B
Investing CF	-5,358,544,089
Is Primary Listing	0
Last Earnings Date	2026-03-04
Last Report Date	2025-12-31
Ma150	139.2
Ma150ch	12.09%
Ma20	166.8
Ma20ch	-6.45%
Net CF	2,025,276,506
Next Earnings Date	2026-05-12
Open	156.1
P FCF Ratio	10.58
P OCF Ratio	6.14
Payment Date	2026-04-29
Ppne	53,633,119,231.8
Price Date	2026-05-08
Price EBITDA	PLN 4.11
Relative Volume	5.35x
Revenue	192,295,784,911x
Tax By Revenue	1.02x
Tr6m	36.46%
Volume	500
Z Score	0.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

WSE/BAY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$0.47 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2026-04-27

Performance

WSE/BAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/BAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+36.7%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

WSE/BAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.3

Neutral momentum band

Price vs 200-day MA

+21.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/BAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/BAY stock rating?

wse/BAY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/BAY analysis?

The full report lives at /stocks/wse/BAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/BAY?

The latest report frames wse/BAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/BAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.